Company ProfilePremium

AMBICA AGARBATHIES & AROMA IND

Company Profile Analysis

Tickers: AMBICAAGAR.NS, 532335.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
AMBICA AGARBATHIES & AROMA IND - Company showcase

Year Founded & Workforce

1946

AMBICA AGARBATHIES & AROMA IND logo

AMBICA AGARBATHIES & AROMA IND Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

AMBICA AGARBATHIES & AROMA IND Overview

Ambica Agarbathies Aroma & Industries Limited is a promoter-controlled, Andhra Pradesh-based micro-cap that combines a legacy regional fast-moving consumer goods franchise — the "Ambica" incense-stick (agarbathi) brand, with roots going back to 1946 — with a small hospitality portfolio anchored by the 86-room Ambica Empire hotel in Vadapalani, Chennai and a smaller property in Visakhapatnam. Agarbathies generate roughly 77% of total income and hotels roughly 23% (FY2026). The brand is strongest in Andhra Pradesh, Telangana and Tamil Nadu, where ICRA has previously described it as well established. The company is capital-heavy for its size (fixed assets of about INR 128 Cr against revenue of INR 141 Cr), lightly profitable (FY2026 PAT INR 3.45 Cr), leverage-dependent (borrowings about INR 96 Cr) and pays no dividend. It trades at roughly 0.37–0.38x book value, reflecting low returns on equity, tight interest cover and family-dominated governance, set against a substantial hard-asset base.


The company's own description (AR FY2025-26, MD&A)

The company describes itself as a manufacturer and seller of incense sticks in India that also operates hotels in Chennai and Visakhapatnam and is involved in film production and distribution, founded in 1946 and based in Eluru, West Godavari district, Andhra Pradesh. It reports two operating segments — the Agarbathies Division and the Hotel Division — although the MD&A text refers to "three segments" before listing only two (an internal drafting inconsistency).

The MD&A frames agarbathi demand around India's position as one of the largest producers, regional consumption (South India estimated at 35% of domestic sales, West 30%, North 18%, East 17%), and a rural skew (about 61% of domestic consumption). It also states that "about 90 foreign countries" use its agarbathies — a claim that sits uneasily with the same report's disclosure of NIL foreign exchange earnings in FY2026.

Independent characterisation

Ambica is best understood as a regional, family-run branded incense manufacturer bolted onto a hotel real-estate holding. The two businesses share no operating synergy; they share a promoter family, a balance sheet and a lender base.

Agarbathies (product revenue): Manufacturing and sale of branded incense sticks, herbal sticks and dhoop through a distributor/stockist network (the Directors' Report thanks "stockiest and distributors"). Revenue is pure product sales; no subscription, licensing or recurring contract revenue. Customers are trade intermediaries (distributors, wholesalers, retailers) serving end-consumers who use incense for religious and household purposes. The company sits in the conversion/branding stage of the value chain: it buys raw agarbathi inputs (bamboo sticks, charcoal/wood powder, perfumery compounds), processes and perfumes them, packs and brands them. Related-party filings also show purchase and sale of "Darbar Agarbathies" with ACP Industries Limited, indicating some traded/outsourced volume.

Hotels (service revenue): Room, food and beverage, banqueting and conference revenue from the Ambica Empire (Chennai) and a Visakhapatnam hotel. Customer types include business travellers, medical tourists (the Chennai property is near several major hospitals), pilgrims (the Vadapalani Murugan temple is a short walk away), wedding and MICE (meetings, incentives, conferences, exhibitions) clients.

Ancillary/legacy activities: Farmland with a resort club house and health centre; wind power generation; film production (three feature films) and film distribution (over 500 films distributed historically). None is reported as a separate segment and their current scale is not publicly disclosed.

Revenue model mix (FY2026)

Revenue typeSourceApprox. share of total income FY2026
Product (agarbathi) salesAgarbathies Division77.5%
Services (hospitality)Hotel Division22.5%
Subscription—0%
LicensingNone disclosed0%

Basis: Segment turnover of INR 11,583.75 lakh (agarbathies) and INR 3,370.27 lakh (hotels) against total income of INR 14,954.02 lakh, AR FY2025-26. Segment figures sum exactly to total income (including other income of INR 845.76 lakh), so other income appears to be allocated within segments.

End-markets

End-marketDescriptionGeography
Religious / household incenseDaily puja, festivals, templesPrimarily Andhra Pradesh, Telangana, Tamil Nadu
Business & medical travel lodgingMid-scale/upscale city hotel roomsChennai (Vadapalani)
Leisure / coastal tourismSmaller hotelVisakhapatnam
MICE & weddingsBanquet halls, conference roomsChennai, Visakhapatnam

Strategy

Stated strategy (themes from AR FY2025-26)

The company does not publish a formal strategy document, investor presentation or medium-term plan. Strategic themes extractable from the annual report are:

  1. Profit retention for business reinvestment: The board declined a dividend because profits are "planned to be ploughed back into the business operations."

  2. Overseas expansion (aspirational): The company "plans to explore and tap overseas markets" and to launch new products first domestically and then overseas.

  3. Hospitality positioning: The MD&A describes a hotel brand "built on service excellence, guest experience, and operational efficiency," targeting business travellers, tourists and event clients, and cites domestic leisure, spiritual tourism, MICE and destination weddings as demand drivers for FY2026.

  4. Scalable processes: The HR section refers to building "robust platforms" and "scalable processes" to support growth (generic language; no specifics).

Announced initiatives (last 24 months)

InitiativeDateDetailStatus
Preferential issue to promoter groupApproved by board 30 May 2026; EGM 30 Jun 2026Up to 8,48,600 shares at INR 25 (INR 10 face + INR 15 premium) raising INR 2.12 Cr for working capitalAllotment evidenced by Sep 2026 shareholding (promoters 46.08%)
CMD continuityFeb 2026Three-year extension of founder-family CMDApproved
Hotel refurbishment2023 (outside window but relevant)Ambica Empire renovated per booking platformsCompleted
CapexFY2025~INR 8 Cr capex (derived); purpose not disclosedCompleted

Sustainability, cost programmes and guidance

ESG commitments: None announced.

Cost programmes: Only generic energy-control statements; no quantified programme.

Medium-term financial targets / guidance: None published.

Products & Services

Agarbathies Division

Product / brandDescriptionTarget customerLaunch yearPricing modelSource
Ambica Durbar BathiFlagship incense stick, multiple fragrances, natural base materialsMass household / religious usersNot disclosed (legacy)MRP retail packs via distributors; prices not disclosedAR FY2025-26
Amrutham (Herbal Bathies)Herbal incense sticks, multiple fragrancesUsers seeking herbal / natural incense—Retail packsAR FY2025-26
Athjisaya DhoopDhoop (stickless/charcoal-free incense) in multiple fragrancesReligious users, dhoop segment—Retail packsAR FY2025-26
Ambica Baba HarathiHerbal agarbathi sub-brandReligious users——Sugandh India
Ambica GowpujaHerbal agarbathi sub-brandReligious users——Sugandh India
Ambica BangaramHerbal agarbathi sub-brandReligious users——Sugandh India
Ambica HeavenHerbal agarbathi sub-brandReligious users——Sugandh India
Fragrance rangeGulab/rose, strawberry, spicy, sandal, rosemary, oriental, opium, myrrh, lavender, jasmine, among othersAllOngoing—Wright Research
Cones and natural incenseIncense cones and natural incense variantsAll——TradingView profile

A family director (Ambica Ramanjaneyulu, a former president of the All India Agarbatti Manufacturers Association) has stated publicly that the family has developed 20–25 herbal agarbathi brands. Not all are confirmed as sold by the listed entity versus related family companies.

Specifications: The company's generic product description notes burning times for agarbathies ranging from 15 minutes to 3 hours depending on size and quality. Product-level specifications are not otherwise disclosed.

Hotel Division

PropertyLocationKey specificationsFacilitiesYearSource
Ambica Empire79 (also cited as 57), 100 Feet Road, Vadapalani, Chennai 60002684–86 rooms incl. 5 suites; 7 floors; 3–4 star classification4 conference/banquet halls (His Highness ~1,800 sq ft, Her Majesty ~800 sq ft, Citrus I and II / Citrus Hall); restaurants Royal Palate, Green Chillies, Andhra Samskruti; pub, gym, spa, steam roomBuilt 1999; renovated 2023Hotel directories; Upstox; Wright Research
Hotel Ambica Sea GreenPlot 1, Kirlampudi Layout, Visakhapatnam 53001733 rooms per directory listing (40 rooms per family interview); 6 floors4 meeting rooms, capacity ~250—Successful Meetings; Sugandh India

Indicative historic published rack rates for Ambica Empire (third-party directory, undated): standard rooms USD 43–53, suites USD 78–83. Current tariffs not disclosed.

Other activities

ActivityDescriptionStatus
Film productionThree feature films producedHistoric; current activity not disclosed
Film distribution500+ films distributedHistoric; current activity not disclosed
Wind powerWind power generationCapacity and revenue not disclosed
Farmland resortFarmland with resort club house and health centreRevenue not disclosed

Financial Narrative

All figures standalone (the company has no subsidiaries as of FY2026). FY2024–FY2026 income-statement lines are summed from reported quarterly results (two decimals); FY2022–FY2023 are annual figures rounded to whole crore by Screener.in from BSE filings. FY2026 and FY2025 headline numbers reconcile to the AR FY2025-26 Directors' Report.

Income statement (INR Cr)

Notes: Gross profit (revenue less cost of materials) is not publicly disclosed in extractable form and is omitted. Operating income (EBIT) is shown via EBITDA less depreciation. FY2022 tax shown as a credit (Screener reports a tax rate of minus 300%). Net income FY2022–FY2023 derived from EPS × 1.7177 Cr shares. Diluted EPS equals basic: no convertible instruments outstanding (AR FY2025-26). The AR FY2025-26 Directors' Report narrative describes FY2025 as a "Loss of Rs. 48.86 Lakhs", contradicting its own table (profit of INR 48.86 lakh) and the quarterly filings; the table is treated as correct.

Margins and growth

Revenue CAGR FY2022–FY2026: approximately 5.0% (INR 116 Cr to INR 141.08 Cr over four years). Longer-term, Screener reports 10-year sales CAGR of 3% and 5-year CAGR of 0% — revenue in FY2026 remains below the FY2020 peak of INR 168 Cr.

Commentary. The P&L tells a story of a business that has not regained its pre-COVID scale. Revenue collapsed from INR 168 Cr (FY2020) to INR 116 Cr (FY2022), stagnated, then fell again to INR 98 Cr in FY2024 before recovering 26% in FY2025 and 14% in FY2026, driven almost entirely by agarbathies (+20% in FY2026) rather than hotels (+4%). The FY2026 recovery was concentrated in an exceptional December 2025 quarter (revenue INR 54.04 Cr, the highest quarter in the series), likely reflecting festive-season and/or bulk trade sales; the March 2026 quarter then fell back to INR 22.27 Cr.

Operating margins are thin and volatile (3.9%–12.1%), consistent with a commoditised regional incense business exposed to raw-material (perfumery compounds, bamboo, charcoal) cost swings. The most important structural feature is that finance costs (INR 11.27 Cr in FY2026) consume more than the entire EBITDA (INR 10.17 Cr); the company is profitable at the pre-tax line only because of other income (INR 8.46 Cr in FY2026, 168% of PBT). The composition of other income is not detailed in reviewed excerpts (likely rental, interest and miscellaneous income); its sustainability is a key analytical question. The effective tax rate is erratic due to deferred tax movements.

Quarterly trend (INR Cr)

Source: Screener.in compilation of quarterly results filed with BSE/NSE.

Q1 FY2027 (June 2026 quarter) revenue declined 18% YoY to INR 24.65 Cr, but EBITDA margin expanded to 12.8% and net profit was broadly flat at INR 1.11 Cr. Trailing-twelve-month (Q2FY26–Q1FY27) revenue is about INR 136 Cr and PAT about INR 3.42 Cr.

Balance sheet (INR Cr, as at 31 March)

Goodwill is presumed nil (no acquisitions). Zerodha's net debt figures imply cash/near-cash of roughly INR 8–10 Cr. Book value per share is computed on 1.7177 Cr shares; third-party sources report slightly different BVPS values due to timing.

Commentary. Borrowings rose 50% in two years (INR 64 Cr in FY2022 to INR 96 Cr in FY2026) even as equity grew only about 11%, pushing debt/equity from 0.63x to 0.85x. The FY2025 increase funded roughly INR 8 Cr of capex (fixed assets up INR 10 Cr, likely hotel refurbishment and/or plant). The FY2026 increase coincided with a INR 21 Cr jump in "other assets" — i.e., working capital build (debtor days rose from 42 to 61) — not productive capex. The asset base is dominated by fixed assets (52% of total assets), principally the hotel properties, which give the equity a tangible-asset underpinning but deliver low returns.

Cash flow (INR Cr)

Source: Screener.in from filed cash flow statements; capex derived as CFO minus FCF.

Commentary. Cash conversion has deteriorated sharply: operating cash flow declined every year from INR 16 Cr (FY2022) to negative INR 7 Cr (FY2026), even as reported profits improved. The FY2026 revenue growth was therefore bought with receivables and working capital, financed by debt. Two consecutive years of negative free cash flow, combined with rising borrowings and a promoter preferential issue of only INR 2.12 Cr explicitly "for working capital", point to a tight liquidity position.

Ratios

ROCE, debtor/inventory/payable days, CCC and working capital days from Screener.in; other ratios computed from tables above.

Commentary. Returns are structurally sub-par: five-year ROE averages about 1% against a cost of equity that for an Indian micro-cap would plausibly exceed 14%. Interest coverage has hovered between 0.8x and 1.5x — dangerously thin — and net debt/EBITDA of 8.7x (FY2026) would normally signal stress. The rise in debtor days to 61 in FY2026 is the most important near-term red flag in the working capital profile.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContentsProducts / services

Agarbathies Division

Manufacturing and trading of incense products

Durbar Bathi, Amrutham (herbal bathies), Athjisaya Dhoop; other Ambica sub-brands

Hotel Division

Owned hotel operations

Ambica Empire (Chennai); Visakhapatnam hotel (Ambica Sea Green); rooms, F&B, banqueting

Revenue by Segment

SegmentFY2025FY2026

Agarbathies Division turnover (INR Cr)

96.59115.84

Hotel Division turnover (INR Cr)

32.3333.70

Total income (INR Cr)

128.92149.54

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment (%) and Segment Margins & Growth (%)

MetricFY2025FY2026

Agarbathies share of total income (%)

74.977.5

Hotel share of total income (%)

25.122.5

Agarbathies YoY growth (%)

—19.9

Hotel YoY growth (%)

—4.2

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

11611797.84123.62141.08

Total expenses excl. interest & depreciation (INR Cr)

10210994.05113.39130.91

EBITDA excl. other income (INR Cr)

1483.7910.2310.17

Other income (INR Cr)

155.355.318.46

Interest / finance cost (INR Cr)

1299.7110.8611.27

Depreciation (INR Cr)

321.691.992.33

Profit before tax (INR Cr)

13-2.262.695.03

Tax (INR Cr)

-1.40.51.402.201.58

Net income (INR Cr)

2.402.53-3.660.493.45

EPS basic (INR)

1.401.47-2.130.292.01

EPS diluted (INR)

1.401.47-2.130.292.01

Dividend per share (INR)

00000

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

EBITDA margin (%)

12.16.83.98.37.2

Operating (EBIT) margin excl. other income (%)

9.55.12.26.75.6

Pre-tax margin (%)

0.92.6-2.32.23.6

Net margin (%)

2.12.2-3.70.42.4

Revenue growth YoY (%)

-18.90.9-16.426.314.1

Effective tax rate (%)

-30017-6281.931.5

Income Statement and Margin Analysis (%)

MetricQ1FY25Q2FY25Q3FY25Q4FY25Q1FY26Q2FY26Q3FY26Q4FY26Q1FY27

Revenue (INR Cr)

23.0133.5136.0531.0530.1434.6354.0422.2724.65

EBITDA (INR Cr)

3.523.092.351.273.091.833.281.973.16

EBITDA margin (%)

15.309.226.524.0910.255.286.078.8512.82

Other income (INR Cr)

1.051.421.511.331.742.141.193.391.98

Interest (INR Cr)

2.652.842.932.442.722.323.073.163.00

PBT (INR Cr)

1.501.250.51-0.571.521.240.901.371.47

Net profit (INR Cr)

1.120.930.38-1.941.140.930.560.821.11

EPS (INR)

0.650.540.22-1.130.660.540.330.480.65

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

219204211224245

Net fixed assets (INR Cr)

122122120130128

Capital work in progress (INR Cr)

00300

Investments (INR Cr)

8891012

Other assets incl. working capital & cash (INR Cr)

90747984105

Total borrowings (INR Cr)

6463678296

Other liabilities (INR Cr)

5336433236

Share capital (INR Cr)

17.1817.1817.1817.1817.18

Reserves (INR Cr)

8588849296

Shareholders' equity (INR Cr)

102105101109113

Book value per share (INR)

59.661.158.863.665.6

Net debt per Zerodha (INR Cr)

———71.9788.17

Cash Flow and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (INR Cr)

16851-7

Investing cash flow (INR Cr)

0-22-56

Financing cash flow (INR Cr)

-17-7-63-1

Capex (INR Cr, derived)

02380

Free cash flow (INR Cr)

1662-7-7

Dividends paid (INR Cr)

00000

Buybacks (INR Cr)

00000

CFO / EBITDA (%)

1121019114-66

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE (%)

2.42.4-3.60.43.1

ROA (%)

1.11.2-1.70.21.4

ROCE (%)

77578

Debt / equity (x)

0.630.600.660.750.85

Net debt / EBITDA (x)

———7.08.7

Interest coverage, EBIT incl. other income / interest (x)

1.081.330.771.251.45

Asset turnover (x)

0.530.570.460.550.58

Debtor days

9160354261

Inventory days

5710302220

Payable days

10817711518

Cash conversion cycle (days)

4053-64963

Working capital days

111162197144161

Region Overview

RegionFY2026

Domestic (India) revenue from operations (INR Cr)

141.08

Export revenue — foreign exchange earnings (INR Cr)

0

Segment Overview — Agarbathies

SegmentAndhra Pradesh / TelanganaTamil NaduRest of IndiaOverseas

Agarbathies

Core market (ICRA: brand well established)

Established market (ICRA)

Distribution extent not disclosed

Company claims product used in ~90 countries; no direct export revenue booked in FY2026

Hotels

Visakhapatnam property

Chennai (Ambica Empire)

——

Capital Markets

MeasureValueSource

Price (19 Oct 2026)

INR 25.2

Screener.in

52-week range

INR 20.0 – 29.9

Screener.in

1-year return

-4%

Screener.in (stock price CAGR)

3-year price CAGR

-13%

Screener.in

5-year price CAGR

+5%

Screener.in

YoY change at 26 May 2026

-22.85%

Upstox

Price reference (INR)

May 2025

Nov 2024

Share price (INR)

27.2230.64

Valuation Multiples

MultipleAmbica (Oct 2026)Notes

P/E (TTM)

12.7x

Screener.in; earlier readings ranged from ~11.6x (Wright, Sep 2026) to 85.5x (Zerodha, on FY2025 earnings)

P/B

0.37–0.38x

Screener.in (BV INR 65.6)

EV/EBITDA

~11.9x (FY2025 basis, Zerodha); ~13x FY2026 basis (derived: INR 43.3 Cr mcap + INR 88.17 Cr net debt ÷ INR 10.17 Cr EBITDA)

Derived figure indicative

EV/Sales

~0.93x (derived: INR 131.5 Cr EV ÷ INR 141.08 Cr)

Derived

Market cap / sales

~0.31x

Derived

Capital Markets (Annual)

MetricFY2022FY2023FY2024FY2025FY2026

Dividend per share (INR)

00000

Dividend payout (%)

00000

Credit Ratings

AgencyRatingDateStatus

ICRA

[ICRA]B (long-term, INR 66 Cr fund-based facilities)

24 Oct 2018

Assigned

ICRA

[ICRA]B (Stable); Withdrawn

16 Nov 2018

Withdrawn

Moody's / S&P / Fitch

Not rated

——

Current

AR FY2025-26 lists credit ratings obtained during the year as "NA"

FY2026

Unrated

Key Events

EventSharesPrice (INR)Proceeds (INR Cr)

Shares outstanding 31 Mar 2026

17,177,400——

Preferential allotment to promoter group (2026)

848,600252.12

Post-allotment shares (derived)

18,026,000——

Analyst Conclusions

Management guidance

None. Management provides no numeric guidance. Qualitative commentary expects good hotel business in coming years and aims to expand overseas and launch new products.

Consensus expectations

None (no analyst coverage).

Bull case

  1. Asset-backed deep value: At ~0.37x book value with INR 128 Cr of fixed assets (largely owned urban hotel real estate), the market capitalisation of ~INR 43–45 Cr is a fraction of the asset base; any asset monetisation or re-rating could unlock material value.

  2. Earnings inflection: PAT recovered from a INR 3.66 Cr loss (FY2024) to INR 3.45 Cr (FY2026), and Q1 FY2027 EBITDA margin reached 12.8% — if margins sustain at 10%+ on INR 140 Cr revenue, EBITDA would rise meaningfully above interest cost.

  3. Promoter alignment: The 2026 preferential allotment lifted promoter holding to 46.08%, reversing the decline from 48.35% (FY2023) and signalling confidence at INR 25/share.

Bear case

  1. Interest consumes operating profit: FY2026 finance cost (INR 11.27 Cr) exceeded EBITDA (INR 10.17 Cr); profits depend on other income whose sustainability is opaque.

  2. Cash burn and leverage creep: Operating cash flow turned negative (minus INR 7 Cr) as debtor days jumped to 61 and borrowings rose to INR 96 Cr; the INR 2.12 Cr equity infusion is small relative to this gap.

  3. Structural under-performance: Ten-year sales CAGR of 3%, five-year ROE of ~1%, no R&D and family-concentrated governance suggest the business has struggled to compound value despite its brand heritage.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableTimingWhat to watch
Q2 FY2027 resultsNov 2026Revenue recovery after -18% Q1; debtor days; interest cost
Q3 FY2027 (festive quarter)Feb 2027Whether Q3 FY2026's INR 54 Cr revenue repeats
FY2027 audited results & cash flowMay 2027Return to positive CFO; borrowing trajectory
Other income compositionOngoingRecurring (rent/interest) vs one-off
Further promoter capital or asset monetisationUnscheduledAny sale/lease of hotel or farmland assets to deleverage
Export initiativeUnscheduledFirst foreign-exchange earnings
Succession planningUnscheduledClarity on leadership after the 75-year-old CMD
Contingent liabilitiesAnnualAny crystallisation of the INR 17.5–19.9 Cr cited by data providers

Analyst verdict

Ambica Agarbathies Aroma & Industries is a classic Indian micro-cap value trap candidate: a genuine heritage brand and a substantial block of hard assets wrapped in a balance sheet and governance structure that have prevented those assets from earning acceptable returns. The FY2026 numbers are the best in six years — revenue of INR 141 Cr, up 14%, and PAT of INR 3.45 Cr — and the agarbathi business demonstrably grew almost 20%. Yet the quality of those earnings is weak. Interest absorbed more than the entire operating profit, other income supplied the bulk of pre-tax profit, and operating cash flow turned negative as receivables swelled. Borrowings have climbed by a third in three years while equity has barely moved.

The bull thesis rests on asset value. The company trades at roughly 0.37x book and about 0.3x sales, with owned hotel properties in Chennai and Visakhapatnam and fixed assets exceeding equity. Promoters have just added capital at INR 25 per share. If management were to monetise non-core assets (film, wind, farmland, or even a hotel) and use proceeds to cut debt, the interest burden would ease sharply and reported earnings would rise disproportionately, likely narrowing the discount.

The bear thesis is that nothing in the disclosure record suggests such a catalyst is coming. There is no stated strategy, no guidance, no R&D, no investor communication, no analyst coverage and no succession plan for a 75-year-old CMD, and the family controls every executive seat. Without a change in capital allocation, the asset discount can persist indefinitely.

The decisive monitorables are a sustained return to positive operating cash flow, stabilisation of borrowings below INR 100 Cr, and any concrete asset-monetisation step. Absent these, the deep discount to book looks justified rather than anomalous.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleDINTenure / appointmentAgeBackgroundShares held (31 Mar 2026)

Ambica Krishna (V.V.P. Krishna Rao Ambica Krishna)

Chairman & Managing Director

00,391,898

CMD since at least 2010-11; re-appointed 13 Feb 2026 to 12 Feb 2029

75+ (AR states he has attained 75)

4+ decades in production, purchase and marketing

13,91,806

Ambica Ramachandra Rao

Whole-time Director

01,678,538

First appointed 30 Nov 2001; re-appointed 2024; retires by rotation 2026, re-appointed

55 (born 26 Feb 1971)

20+ years in purchase and marketing of agarbathies; undergraduate

6,16,950

Satyavathi Perla

Whole-time Director (woman director)

07,141,289

Re-appointed at 29th AGM (2024)

——

1,39,989

Mallikarjunarao Voleti

Independent Director; Chair of Audit, NRC and SRC

————0

B V Subrahmanyeswarao

Independent Director

————0

Chunduru Anjaneya Swamy

Independent Director

08,810,748

Re-appointed at 30th AGM (26 Sep 2025)

——0

Alapati Hanuma (Ambica Hanuma)

Chief Financial Officer

———

Family member (per Sugandh India family list)

—

Uma Gayathri

Company Secretary & Compliance Officer

—————

“—” = not publicly disclosed.

Directors' Remuneration

NameSalary & perksBonusStockTotal

Ambica Krishna (CMD)

1,200,000001,200,000

Satyavathi Perla (WTD)

1,200,000001,200,000

Ambica Ramachandra Rao (WTD)

0000

Independent directors (each)

0000

Shareholding Trend

Holder categoryDec 2023Mar 2024Mar 2025Mar 2026Jun 2026Sep 2026

Promoters (%)

44.8643.6943.4143.4143.4146.08

FIIs (%)

0.000.030.000.000.000.00

Public (%)

55.1456.2956.5856.5856.5753.91

Number of shareholders

7,9178,6808,8308,3358,2458,351

Board & Management Changes

DateChangeContext

26 Sep 2025

Chunduru Anjaneya Swamy re-appointed Independent Director

Second term

12 Feb 2026

Ambica Krishna re-appointed CMD for 3 years from 13 Feb 2026

Aged 75; special resolution required

29 Sep 2026

Ambica Ramachandra Rao re-appointed on rotation; CMD re-appointment ratified

All resolutions passed at 31st AGM

Competitive Landscape

Key Competitors

CompetitorOwner / listingFlagship brand(s)Relative positioning vs Ambica

ITC Limited

Listed (NSE: ITC)

Mangaldeep

National leader; ITC stated (2020) Mangaldeep had ~10% share of a ~INR 8,800 Cr market — #1 in dhoop, #2 in agarbathi; vastly larger scale and distribution

N. Ranga Rao & Sons Pvt Ltd

Private

Cycle Pure Agarbathies

National/global leader; strong South India overlap; exports widely

Mysore Deep Perfumery House

Private

Zed Black

Major national player; investing in automation

Moksh Agarbatti Co

Private

Moksh

National brand

Hari Darshan Sevashram Pvt Ltd

Private

Hari Darshan

Strong in North/West India

Patanjali Ayurved Ltd

Private

Patanjali Aastha

Herbal positioning; mass distribution

Hem Corporation Pvt Ltd

Private

HEM

Export-led

Shree Kalpana Perfumery Works

Private

Kalpana

Regional/national

B.V. Aswathiah & Bros

Private

Nandi

Karnataka-based, South India overlap

Godrej Consumer Products

Listed (NSE: GODREJCP)

Goodknight agarbatti (repellent, launched Feb 2024)

Adjacent repellent-incense format

Kanpur Flowercycling Pvt Ltd

Private

Phool

Premium, recycled-flower incense

Peer Comparison FY2026

MetricAmbica (FY2026)ITC Mangaldeep

Incense revenue

INR 115.8 Cr (segment turnover)

Not separately disclosed (ITC reports within "Other FMCG")

Growth

+19.9% (agarbathi segment)

—

Margins

Company EBITDA 7.2%

Not disclosed at brand level

R&D intensity

0%

Not disclosed at brand level

Market share

~1.3% (derived: INR 115.8 Cr ÷ INR 8,800 Cr)

~10% (ITC, 2020)

“—” = not publicly disclosed.

Company Snapshot

$16.3M

Revenue

1946

Founded

West Godavari District, India

Headquarters

SWOT Analysis

Strengths

  • Heritage brand: Business roots in 1946; ICRA (Oct 2018) cited the "Ambica" brand as reputed and well established in Andhra Pradesh, Telangana and Tamil Nadu.
  • Agarbathi momentum: Agarbathi segment turnover grew 19.9% to INR 115.84 Cr in FY2026 (AR FY2025-26).
  • Hard-asset backing: Net fixed assets of INR 128 Cr (FY2026) — 113% of equity — principally hotel real estate in Chennai and Visakhapatnam.
  • Profit recovery: PAT rose from a INR 3.66 Cr loss (FY2024) to INR 0.49 Cr (FY2025) and INR 3.45 Cr (FY2026).
  • Clean regulatory record: No capital-market non-compliance, penalties or strictures in the last three years; no auditor qualifications; no IBC proceedings (AR FY2025-26).
  • Promoter commitment: Promoters subscribed INR 2.12 Cr of new equity in 2026, lifting their stake from 43.41% to 46.08%.

Weaknesses

  • Interest burden: Finance cost of INR 11.27 Cr exceeded EBITDA of INR 10.17 Cr in FY2026; interest coverage (EBIT incl. other income) only 1.45x.
  • Dependence on other income: Other income of INR 8.46 Cr equalled 168% of FY2026 PBT.
  • Negative cash flow: Operating cash flow fell from INR 16 Cr (FY2022) to minus INR 7 Cr (FY2026); FCF negative two years running.
  • Low returns: ROE averaged ~1% over five years (Screener: 1% 5-year, 0% 3-year); FY2026 ROE 3.1%.
  • No R&D: R&D expenditure NIL (AR FY2025-26, Annexure I).
  • Governance concentration: CMD aged 75+ combines chair and CEO roles; all executive directors and KMPs are from one family; independent directors receive no sitting fees.

Opportunities

  • Large, growing market: India incense market ~USD 1.2–1.26 bn growing ~5% annually (IMARC, ReportCubes); South India is the largest region.
  • Herbal premiumisation: Existing Amrutham herbal line and 20–25 herbal sub-brands can be leveraged as consumers shift to natural incense.
  • Exports: Company states intent to tap overseas markets; current direct export revenue is zero, so any traction is incremental.
  • Hospitality tailwinds: Company MD&A cites recovery in foreign arrivals, spiritual tourism, MICE and weddings; Ambica Empire was renovated in 2023.
  • Asset monetisation: Hotel and farmland real estate could be leased, sold or redeveloped to deleverage (not announced).
  • Valuation re-rating: Stock trades at ~0.37–0.38x book (Screener, Oct 2026); improved cash conversion could narrow the discount.

Threats

  • National-brand competition: ITC's Mangaldeep alone held ~10% share (2020), and the top 5 players control ~58% of the market (ReportCubes).
  • Working capital stress: Debtor days rose from 42 to 61 in FY2026 (Screener).
  • Rising leverage: Borrowings up from INR 63 Cr (FY2023) to INR 96 Cr (FY2026); net debt/EBITDA ~8.7x.
  • Alternative accommodation: Company itself flags OYO/Airbnb competition and cost pressure in hotels.
  • Key-person risk: CMD has attained 75; no succession plan disclosed.
  • Revenue volatility: Q1 FY2027 revenue fell 18% YoY to INR 24.65 Cr after a record Q3 FY2026.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
21 May 2025Intimation of board meeting to approve FY2025 audited results; trading window closed from 1 Apr 2025Routine
28 May 2025FY2025 audited results: revenue INR 123.62 Cr (+26%), PAT INR 0.49 Cr; Q4 FY25 net loss INR 1.94 CrReturn to marginal profit after FY2024 loss
29 Jul 2025Board meeting (NRC also met)Governance
6 Aug 2025Intimation of Q1 FY2026 results meetingRoutine
13 Aug 2025Q1 FY2026 results: revenue INR 30.14 Cr (+31% YoY), PAT INR 1.14 CrStrong start to year
2 Sep 2025Board meeting approves AGM notice / AR FY2024-25Governance
Sep 202530th Annual Report FY2024-25 filedDisclosure
26 Sep 202530th AGM; Independent Director Chunduru Anjaneya Swamy re-appointedBoard continuity
5 Nov 2025Intimation of Q2 FY2026 results meetingRoutine
10 Nov 2025Q2 FY2026 results: revenue INR 34.63 Cr, PAT INR 0.93 CrSteady
6 Feb 2026Intimation of Q3 FY2026 results meetingRoutine
12 Feb 2026Q3 FY2026 results: record quarterly revenue INR 54.04 Cr; PAT INR 0.56 CrRevenue spike; margin dilution
12 Feb 2026Board re-appoints Ambica Krishna as CMD for 3 years from 13 Feb 2026Founder continuity; age >75
12 Feb 2026Separate meeting of independent directorsGovernance
Mar 2026 quarterShareholding pattern: promoters 43.41%; shareholders 8,335Stable
May 2026Share price at ~INR 23.8, down ~23% YoY (Upstox, 25–26 May 2026)Weak sentiment
30 May 2026FY2026 audited results: revenue INR 141.08 Cr (+14%), PAT INR 3.45 Cr (7x YoY)Best profit since FY2020
30 May 2026Board approves preferential issue of up to 8,48,600 shares to promoter group (allottees named include Perla Ambica Ramachandran and Ambica Eswar)Promoter capital infusion; signals confidence but small size
30 Jun 2026EGM approves preferential issue at INR 25/share (INR 2.12 Cr) for working capitalApproved
Jun 2026 quarterShareholding pattern shows promoters 43.41% (pre-allotment)—
Aug 2026Q1 FY2027 results: revenue INR 24.65 Cr (-18% YoY), PAT INR 1.11 Cr, EBITDA margin 12.8%Revenue softness, margin strength
25 Aug 2026Board approves AR FY2025-26 and AGM noticeGovernance
4 Sep 202631st Annual Report FY2025-26 filed with BSE/NSEDisclosure
Sep 2026 quarterShareholding pattern: promoters 46.08% (+2.67 pp), confirming allotmentPromoter stake up
26 Sep 2026Trading window closed from 1 Oct 2026 until 48 hours after Q2 FY2027 resultsRoutine
29 Sep 202631st AGM: adoption of accounts, director re-appointment and CMD re-appointment passed; scrutiniser's report filedGovernance
15 Oct 2026Regulation 74(5) certificate for quarter ended 30 Sep 2026 (no demat/remat requests)Routine

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Income Statement: Revenue & Gross Profit: Revenue from operations rose from INR 1,160 Mn in FY2022 to INR 1,410.8 Mn in FY2026.
AMBICA AGARBATHIES & AROMA IND — Income Statement: Revenue & Gross Profit
Series (INR Mn)FY2022FY2023FY2024FY2025FY2026
Revenue from operations1,1601,170978.41,236.21,410.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Ambica Agarbathies Aroma & Industries Ltd — 31st Annual Report FY2025-26 (NSE filing, 4 Sep 2026) (nsearchives.nseindia.com)
  2. 29th Annual Report FY2023-24 (NSE filing, 4 Sep 2024) (nsearchives.nseindia.com)
  3. 16th Annual Report FY2010-11 (BSE) (bseindia.com)
  4. Board Meeting Outcome, 30 May 2026 (NSE) (nsearchives.nseindia.com)
  5. Directors' Report FY2024-25 (IIFL) (indiainfoline.com)
  6. Screener.in standalone financials, shareholding and announcements (screener.in)
  7. NSE prior intimations (Feb 2025, May 2025, Aug 2025, Nov 2025, Feb 2026): nsearchives.nseindia.com
  8. ScanX — preferential issue approval (scanx.trade)
  9. Bigul — 2023 fund-raising deferral announcements (bigul.co)
  10. ICRA rating rationale (24 Oct 2018) (icra.in)
  11. ICRA rating withdrawal (16 Nov 2018) (icra.in)
  12. Zerodha Markets (net debt, multiples) (zerodha.com)
  13. Simply Wall St (management, coverage) (simplywall.st)
  14. Upstox (price, business description) (upstox.com)
  15. Wright Research (factories, products, hotel facilities) (wrightresearch.in)
  16. MarketsMojo company CV (incorporation date) (marketsmojo.motilaloswal.com)
  17. Kotak Securities profile (kotaksecurities.com)
  18. Sugandh India — "The Alchemy of Aroma: Ambica Agarbatties" (sugandhindia.in)
  19. Ambica Empire hotel listings: successfulmeetings.com; hotels.com; travelweekly-asia.com
  20. Hotel Ambica Sea Green listing (successfulmeetings.com)
  21. afaqs! — ITC Mangaldeep interview (market size, share) (afaqs.com)
  22. IMARC — India incense sticks market (imarcgroup.com)
  23. ReportCubes — India incense sticks market (thereportcubes.com)
  24. Value Market Research (via GII) — global incense sticks market (giiresearch.com)
  25. Fyers — peer comparison (fyers.in)
  26. TradingView — company profile (in.tradingview.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.